University of Pennsylvania: Multiple Myeloma trials

The registry lists 13 Multiple Myeloma studies with University of Pennsylvania as lead sponsor. 0 are open to participants now and 3 have results posted.

Phase 1 9Phase 2 4(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• CART-19 Post-ASCT for Multiple MyelomaTerminatedNCT02794246Phase 2Results posted
• Id-KLH Vaccine + T Cells in Subjects With Myeloma Undergoing TransplantCompletedNCT01426828Phase 2Results posted
• Combination Immunotherapy and Autologous Stem Cell Transplantation for MyelomaCompletedNCT01245673Phase 2Results posted
• Cevostamab Following CAR T Cell Therapy for RRMMActive, not recruitingNCT05801939Phase 2
• CART-38 in Adult AML and MM PatientsTerminatedNCT05442580Phase 1
• Tasquinimod for the Treatment of Relapsed or Refractory MyelomaTerminatedNCT04405167Phase 1
• Up-front CART-BCMA With or Without huCART19 in High-risk Multiple MyelomaActive, not recruitingNCT03549442Phase 1
• NY-ESO-1-redirected CRISPR (TCRendo and PD1) Edited T Cells (NYCE T Cells)TerminatedNCT03399448Phase 1
• CART-BCMA Cells for Multiple MyelomaCompletedNCT02546167Phase 1
• CART-19 for Multiple MyelomaCompletedNCT02135406Phase 1
• Umbilical Cord Blood Transplant for Hematological MalignanciesCompletedNCT00891592Phase 1
• Phase I/II Clinical Trial Combining hTERT Tumor Vaccine & Autologous T Cells in Patients With Advanced MyelomaCompletedNCT00834665Phase 1
• Trial of Donor Lymphocyte Infusion (DLI) and Activated DLI Following Relapse After Allogeneic Stem Cell TransplantTerminatedNCT00674427Phase 1